Advocacy partner: Phaware Global Association
About the Phaware Global Association
Phaware Global Association® is a 501(c)3 organization dedicated to raising global pulmonary hypertension awareness and creating innovative technology for PH research. Phaware® was co-founded by pulmonary hypertension community members who together bring unique for-profit expertise to the nonprofit world. Our goal is to use technology to create a global footprint and address PH patients’ needs around the world.
Contact: Steve Van Wormer – President/Managing Director
Phone: 818-395-3529
Email: [email protected]
I’m Aware That I’m Rare: the phaware® podcast
New Episodes Every Tuesday
Join the #phaware conversation in the podcast series devoted to raising pulmonary hypertension awareness. Engage for a cure with impactful, educational, and more importantly, hopeful stories from members of the global PH and rare disease community.
Heart Works – phaware®
The New Mobile PH Research and Resource App
About the Heart Worksâ„¢ App:
Introducing Heart Works – phaware®, the future of patient-driven pulmonary hypertension management. Heart Works redefines how you live with and manage pulmonary hypertension by putting the power of innovative health technology right in your hands.
With seamless integration through your iPhone®, Apple Watch®, or Android® devices, Heart Works empowers patients like never before. By leveraging wearable tech, you can now effortlessly contribute to remote research and clinical trials, perform activity challenges typically done in hospitals, and deliver critical data directly to researchers – all from the comfort of your home.
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
Recent Posts
- Joy trumps grief as my mom embarks on a rare trip
- Seralutinib narrowly misses goal in PAH trial, but benefits seen for patients
- The increasing use of AI in healthcare understandably prompts questions
- Why writing letters is important for both sender and recipient
- Signaling molecule in exosomes may limit PAH right-heart damage



